Trial intelligence / Profile preview

Concerta for Tobacco Dependence

NCT00549640Phase 2Completed

Sponsor
Mayo Clinic
Start
Jan 2008
Primary completion
Jan 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of methylphenidate in tobacco dependence, sponsored by Mayo Clinic. Started Jan 2008; status: completed.

02

Drugs

methylphenidate
03

Conditions

tobacco dependence

Beyond the preview

Go deeper on NCT00549640.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00549640.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call